We leverage our scientific expertise along with our technology suite to enable the right data to be collected, at the right time, with the right solution, in the right setting
Decentralized Clinical Trials
How we deliver successful optimized trials
Solution
The integrated products comprising our suite each offer comprehensive functionality to meet the needs of all trials, without surprise capability gaps
Empathy
Our clinical and scientific experts help design the optimal balance between site and home activities as well as assessments to ensure the easiest study journey for patients and sites
Strategic Alliances
Through key partnerships with market-leading global trial support providers, we facilitate the delivery of home research services alongside Signant’s trial optimization solutions
Science
Over 50 full-time clinicians and scientists oversee all aspects of study and solution design, ensuring optimal measurement strategy and measure validity when migrated to remote administration
Service
Experienced global project delivery teams, including end-to-end procurement and logistics, COA scale and license management, and 24/7 local language help desks drive hassle-free implementations
Scale
Extensive global reach with project teams in all time zones, combined with global architecture and infrastructure, facilitates hundreds of new trials per year, anywhere across the world
End-to-End Solutions
Remote Data Capture and Monitoring
- Device-agnostic, remote ePRO data capture
- Integrated wearables and sensors
- Video-enabled remote clinician ratings
- Central rating services
- Remote eConsent and reconsent management
Telemedicine Solutions
- Video visits using our proprietary telemedicine platform designed specifically for clinical trials
- Comprehensive telemedicine platform
- Virtual site initiation & monitoring
Study Design and Consulting Services
- Clinical and scientific consulting on measurement validity when migrating from site to remote
- Decentralized study and solution design consulting
Logistical Support
- Full direct-to-patient medication provision through RTSM
- Partner-supported home research services
- Device-agnostic, remote ePRO data capture
- Integrated wearables and sensors
- Video-enabled remote clinician ratings
- Central rating services
- Remote eConsent and reconsent management
- Video visits using our proprietary telemedicine platform designed specifically for clinical trials
- Comprehensive telemedicine platform
- Virtual site initiation & monitoring
- Clinical and scientific consulting on measurement validity when migrating from site to remote
- Decentralized study and solution design consulting
- Full direct-to-patient medication provision through RTSM
- Partner-supported home research services
Why choose Signant SmartSignals?
High quality evidence
Ensure accurate and reliable evidence generation, and valid measures when migrating from clinic to remote administration, by leveraging our leading scientific expertise to guide your measurement strategy
Scale & Service
Customers trust Signant because of our ability to deliver high quality studies they can depend on, with the same service level, whether a pilot or a pivotal study
Proven Expertise
Signant has been decentralizing aspects of clinical trials for 20+ years. Trust us to optimize your study
Integration
Leverage our integrated product suite, or integrate components with other third-party solutions
Trust our proven heritage in trial optimization and decentralization
For more than twenty years, Signant has pioneered the application of technology, scientific services, as well as project delivery infrastructure to optimize clinical evidence generation and remote clinical trial conduct. By doing this, we have supported 28% of recent novel drug approvals by FDA and EMA.
2001
First remote ePRO study
2007
First central rating study, remote ClinRO assessment as primary outcome
2012
First BYOD ePRO study
2015
First video-enabled remote clinician ratings
2016
Remote scoring of movement disorders results in successful product approval
2017
First remote sample collection
2018
First direct to patient medication supply
2019
Central rating of primary outcome for first psychedelic compound to treat MDD
2020
First study including remote photographic image capture and central review
2020
First virtual site monitoring use for CRA site inspection
Want to learn more?
Ensure accurate and reliable evidence generation - contact our team today